• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管植入电子设备分析在尸检中的临床推论。

Clinical Inferences of Cardiovascular Implantable Electronic Device Analysis at Autopsy.

机构信息

Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

出版信息

J Am Coll Cardiol. 2016 Sep 20;68(12):1255-64. doi: 10.1016/j.jacc.2016.06.052.

DOI:10.1016/j.jacc.2016.06.052
PMID:27634115
Abstract

BACKGROUND

Cardiovascular implantable electronic device (CIED) removal and interrogation are recommended at autopsy in suspected cases of sudden cardiac death, but data on the role of nonselective post-mortem CIED (pacemaker or defibrillator) analysis in this setting are lacking.

OBJECTIVES

This study undertook an institutional registry analysis to determine the utility of systematic routine CIED removal, interrogation, and analysis at autopsy.

METHODS

From May 19, 2009, to May 18, 2015, autopsy subjects with a CIED at a Johns Hopkins University medical institution (Baltimore, Maryland) underwent CIED removal and interrogation by an electrophysiologist for clinical alerts. The CIED was then submitted for technical analysis by the manufacturer. The CIED interrogation, the manufacturer's technical analysis, and the final autopsy report were all cataloged in the Johns Hopkins Post-mortem CIED Registry.

RESULTS

A total of 2,025 autopsies were performed; 84 subjects had CIEDs removed and analyzed. These devices included 37 pacemakers and 47 defibrillators. Overall, 43 subjects had died suddenly, and 41 had not died suddenly. Significant clinical alerts (sustained tachyarrhythmias or an elevated fluid index value) were seen in 62.8% cases of sudden deaths. In the nonsudden death cohort, 19.5% displayed a significant clinical alert. Significant association of CIED alerts were noted when comparing sudden deaths versus nonsudden deaths (p < 0.001), defibrillators versus pacemakers (p < 0.005), and cardiac versus noncardiac causes of death (p < 0.001). Manufacturer analyses revealed a case of premature pacemaker battery depletion, as well as a hard reset in a defibrillator as a result of cold exposure.

CONCLUSIONS

Post-mortem CIED analysis was clinically useful in assisting with determination of the timing, mechanism, and cause of death in the majority of sudden deaths and in almost 20% of nonsudden deaths. The authors advocate CIED removal with analysis as an important diagnostic tool in all autopsies and to assist manufacturers in identifying potentially fatal device failures.

摘要

背景

在疑似心源性猝死的病例中,建议在尸检时取出并检查心血管植入式电子设备(CIED),但目前尚缺乏在这种情况下非选择性死后 CIED(起搏器或除颤器)分析作用的数据。

目的

本研究通过机构注册分析,确定系统常规 CIED 取出、检查和尸检分析的实用性。

方法

从 2009 年 5 月 19 日至 2015 年 5 月 18 日,在马里兰州巴尔的摩市的约翰霍普金斯大学医疗机构进行尸检的 CIED 患者由电生理学家进行 CIED 取出和检查,以获取临床警报。然后,制造商对 CIED 进行技术分析。制造商的技术分析、CIED 检查和最终尸检报告均被列入约翰霍普金斯死后 CIED 登记处。

结果

共进行了 2025 次尸检,其中 84 例患者取出并分析了 CIED。这些设备包括 37 个起搏器和 47 个除颤器。总的来说,43 名患者突然死亡,41 名患者没有突然死亡。在突然死亡病例中,62.8%有明显的临床警报(持续性快速性心律失常或液体指数值升高)。在非突然死亡组中,19.5%有明显的临床警报。在将突然死亡与非突然死亡进行比较时,注意到 CIED 警报有显著关联(p<0.001),在比较除颤器与起搏器(p<0.005)以及心源性与非心源性死亡原因(p<0.001)时,也有显著关联。制造商的分析显示了一个起搏器电池过早耗尽的病例,以及一个除颤器因暴露在寒冷中而硬重置的病例。

结论

在大多数突然死亡病例中,尸检 CIED 分析在协助确定死亡时间、机制和原因方面具有临床意义,在近 20%的非突然死亡病例中也具有临床意义。作者主张在所有尸检中取出并分析 CIED,作为一种重要的诊断工具,并协助制造商识别潜在致命的设备故障。

相似文献

1
Clinical Inferences of Cardiovascular Implantable Electronic Device Analysis at Autopsy.心血管植入电子设备分析在尸检中的临床推论。
J Am Coll Cardiol. 2016 Sep 20;68(12):1255-64. doi: 10.1016/j.jacc.2016.06.052.
2
Cardiac Implantable Electronic Device Interrogation at Forensic Autopsy: An Underestimated Resource?法医尸检中心脏植入式电子设备的检测:被低估的资源?
Circulation. 2018 Jun 19;137(25):2730-2740. doi: 10.1161/CIRCULATIONAHA.117.032367.
3
Sudden Death in Patients With Cardiac Implantable Electronic Devices.心脏植入式电子设备患者的猝死。
JAMA Intern Med. 2015 Aug;175(8):1342-50. doi: 10.1001/jamainternmed.2015.2641.
4
Cardiovascular implantable electronic device function and longevity at autopsy: an underestimated resource.心血管植入式电子设备在尸检时的功能与寿命:一种被低估的资源。
Heart Rhythm. 2016 Oct;13(10):1971-6. doi: 10.1016/j.hrthm.2016.05.023. Epub 2016 May 27.
5
Forensic perspectives on postmortem CIED interrogation: A systematic review and meta-analysis.法医视角下的死后埋藏式心脏转复除颤器检测:系统评价与荟萃分析。
Forensic Sci Int. 2024 Jun;359:112001. doi: 10.1016/j.forsciint.2024.112001. Epub 2024 Mar 19.
6
Postmortem interrogation of cardiac implantable electrical devices may clarify time and cause of death.对植入式心脏电子装置进行尸检分析可能会明确死亡时间和死因。
Int J Legal Med. 2019 May;133(3):883-888. doi: 10.1007/s00414-018-1932-3. Epub 2018 Sep 20.
7
Post mortem pro life - Should we analyse the implantable devices after death? A systematic review.死后支持生命 - 我们是否应该在死亡后分析可植入设备?系统评价。
Int J Cardiol. 2019 Apr 1;280:89-94. doi: 10.1016/j.ijcard.2019.01.024. Epub 2019 Jan 9.
8
Postmortem Interrogation of Cardiac Implantable Electronic Devices: A 15-Year Experience.心脏植入式电子设备的尸检分析:15年经验
JACC Clin Electrophysiol. 2022 Mar;8(3):356-366. doi: 10.1016/j.jacep.2021.10.011. Epub 2021 Dec 22.
9
Determination of time of death by blinded post-mortem interrogation of cardiac implantable electrical devices.通过盲法死后询问心脏植入式电子设备来确定死亡时间。
Sci Rep. 2022 May 17;12(1):8199. doi: 10.1038/s41598-022-12390-3.
10
Radiotherapy-Induced Malfunction in Contemporary Cardiovascular Implantable Electronic Devices: Clinical Incidence and Predictors.当代心血管植入式电子设备放疗致故障:临床发生率及预测因素。
JAMA Oncol. 2015 Aug;1(5):624-32. doi: 10.1001/jamaoncol.2015.1787.

引用本文的文献

1
Postmortem data collection protocol for cardiac implantable electronic devices by the forensic pathologists: how to avoid conflicts of interest and minimize data loss?法医病理学家对心脏植入式电子设备进行尸检数据收集的协议:如何避免利益冲突并尽量减少数据丢失?
Int J Legal Med. 2025 Aug 11. doi: 10.1007/s00414-025-03579-y.
2
Peri-mortem arrhythmias in the non-cardiac intensive care unit.非心脏重症监护病房中的濒死心律失常
Nurs Crit Care. 2025 Mar;30(2):e13097. doi: 10.1111/nicc.13097. Epub 2024 Jun 3.
3
Sacubitril/valsartan and arrhythmic burden in patients with heart failure and reduced ejection fraction: a systematic review and meta-analysis.
沙库巴曲缬沙坦与射血分数降低的心力衰竭患者的心律失常负担:一项系统评价和荟萃分析。
Heart Fail Rev. 2023 Nov;28(6):1395-1403. doi: 10.1007/s10741-023-10326-1. Epub 2023 Jun 29.
4
Determination of time of death by blinded post-mortem interrogation of cardiac implantable electrical devices.通过盲法死后询问心脏植入式电子设备来确定死亡时间。
Sci Rep. 2022 May 17;12(1):8199. doi: 10.1038/s41598-022-12390-3.
5
Safety verification of carbon-ion radiotherapy for patients with cardiac implantable electronic devices (CIEDs).心脏植入式电子设备(CIEDs)患者碳离子放疗的安全性验证。
J Radiat Res. 2022 Jan 20;63(1):122-127. doi: 10.1093/jrr/rrab105.
6
2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families.2020年亚太心律学会/美国心律学会关于不明原因猝死死者及心脏骤停患者及其家属调查的专家共识声明
J Arrhythm. 2021 Apr 8;37(3):481-534. doi: 10.1002/joa3.12449. eCollection 2021 Jun.
7
2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families.2020 年 APHRS/HRS 关于猝死和心搏骤停患者及其家属尸检调查的专家共识声明
Heart Rhythm. 2021 Jan;18(1):e1-e50. doi: 10.1016/j.hrthm.2020.10.010. Epub 2020 Oct 19.
8
Sacubitril/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction.沙库巴曲缬沙坦可减少心力衰竭射血分数降低患者的室性心律失常,同时逆转左心室重构。
Clin Res Cardiol. 2019 Oct;108(10):1074-1082. doi: 10.1007/s00392-019-01440-y. Epub 2019 Feb 20.
9
Reply.回复。
Virchows Arch. 2018 Feb;472(2):295-296. doi: 10.1007/s00428-017-2245-5. Epub 2017 Oct 17.
10
Implantable Cardioverter-Defibrillators for Secondary Prevention of Sudden Cardiac Death: A Review.用于心脏性猝死二级预防的植入式心脏复律除颤器:综述
J Am Heart Assoc. 2017 Mar 3;6(3):e005515. doi: 10.1161/JAHA.117.005515.